Objectives: This study aimed to examine the size and trends in payments from the pharmaceutical industry to healthcare professional organisations (HPOs) in the United Kingdom (UK), and to characterise the conflict of interest (COI) management plans by HPOs who received large payments.
Design: Cross-sectional analysis of non-research payments disclosed in the Disclosure UK database from 2015 to 2021.
Setting: United Kingdom.